MSME (Udyam registered) Ministry of MSME
- Category
- Small (2023-24)
- Udyam number
- UDYAM-AS-03-0019457
Intag Remedies Private Limited
Intag Remedies Private Limited - pharma in Guwahati, Assam, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹14.94 Cr
▲ 7% YoY
Net profit · FY 2025
₹64.46 Lakh
Net margin 4.3%
EBITDA · FY 2025
₹89.55 Lakh
EBITDA margin 6%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹5 Lakh
Issued & subscribed
Company age
18 yrs
Est. 2008
Employees · EPFO
56
Provident fund records
Directors on board
5
As per MCA filings
About Intag Remedies Private Limited
Data last updated:
Intag Remedies Private Limited is a private limited company based in Guwahati, Assam, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 19 March 2008 and has been in existence for over 18 years.
The company is registered with the Registrar of Companies (ROC), Guwahati, under CIN U51397AS2008PTC008633. Its GSTIN is 18AACCI1905P1ZC (Assam). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Deepak Damani and Narayan Prasad Gattani.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C/O Deepak Pharmaceuticals S.C. Goswami Road Pan Bazar, Guwahati, Assam, India – 781001.
As per the financials filed for FY 2025, the company reported a revenue of ₹14.94 Cr, a growth of 7% compared to the previous year. For the same year it recorded a net profit of ₹64.46 Lakh (net margin 4.3%) and EBITDA of ₹89.55 Lakh (EBITDA margin 6%). Revenue has grown at a compounded annual rate (CAGR) of 9% over three years and 6% over five years.
The company has about 56 employees on its provident fund (EPFO) records.
Court records list 4 cases involving the company, including 1 filed by the company and 3 filed against it; 2 cases are pending.
Intag Remedies Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-AS-03-0019457). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U51397AS2008PTC008633
Registration Number 008633
Incorporation Date 19 March 2008
ROC Guwahati
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-AS-03-0019457
Recognitions & Rankings of Intag Remedies
Contact details
Intag Remedies Private Limited's registered office is in Guwahati, Assam. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressC/O Deepak Pharmaceuticals S.C. Goswami Road Pan Bazar, Guwahati, Assam, India – 781001
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Intag Remedies Private Limited, buy the company report.
Comprehensive company report
Intag Remedies Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Intag Remedies is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Intag Remedies Private Limited, buy the company report.
Financials of Intag Remedies Private Limited
FY 2025 filings availableIntag Remedies Private Limited reported revenue of ₹14.94 Cr (up 7% YoY) for FY 2025.
Revenue · FY 2025
₹14.94 Cr ▲ 7%
Net profit · FY 2025
₹64.46 Lakh margin 4.3%
EBITDA · FY 2025
₹89.55 Lakh margin 6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 7%
3 years · compounded
▲ 9%
5 years · compounded
▲ 6%
EBITDA CAGR growth
1 year
▼ 8%
3 years · compounded
▲ 2%
5 years · compounded
▲ 6%
Revenue has grown at a compounded annual rate (CAGR) of 6% over five years, including 7% growth in the latest year. EBITDA fell 8% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹89.55 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹64.46 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6% | ||||
| Net Profit Margin | 4.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Intag Remedies Private Limited, buy the company report.
Board of directors of Intag Remedies Private Limited
Intag Remedies has 5 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Deepak Damani | Director | 16 Jul 2008 | 18 Years 3 Months | Current |
| Narayan Prasad Gattani Also directs: Precaution Healthcare Private Limited | Director | 19 Mar 2008 | 18 Years 7 Months | Current |
| Sarda Devi Damani | Director | 19 Mar 2008 | 18 Years 7 Months | Current |
| Madhu Sudan Periwal | Director | 19 Mar 2008 | 18 Years 7 Months | Current |
| Bijay Damani Kumar | Director | 19 Mar 2008 | 18 Years 7 Months | Current |
Peer comparison
Intag Remedies Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Medisearch Laboratories (Bombay) Private Limited | ₹15.07 Cr (FY 2025) | -23.0% | Thane, Maharashtra, India | |||
| Triox Pharmchem Private Limited | ₹15.01 Cr (FY 2025) | -8.0% | Mumbai, Maharashtra, India | |||
| Pharvinex Healthcare Private Limited | ₹15.01 Cr (FY 2022) | 43.0% | Secunderabad, Telangana, India | |||
| Intag Remedies Private Limitedthis company | ₹14.94 Cr (FY 2025) | ₹64.46 Lakh | 4.3% | 7.0% | 56 | Guwahati, Assam, India |
| Acme Therapeutics (I) Private Limited | ₹14.81 Cr (FY 2025) | -8.0% | Panchkula, Haryana, India |
To see the full peer comparison of Intag Remedies Private Limited, buy the company report.
Auditor
Intag Remedies Private Limited is audited by MANISH AGARWALLA & Co for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MANISH AGARWALLA & Co | FY 2023 | 326988E |
Shareholding
The shareholding of Intag Remedies Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Intag Remedies Private Limited, buy the company report.
Legal cases
Intag Remedies Private Limited has 4 court cases on record: 1 filed by Intag Remedies, 3 filed against it. 2 cases are pending and 2 are disposed.
Total cases
4
Filed by the company
1
Filed against the company
3
Pending
2
Disposed
2
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 4 | 3 | 2 |
Cases on record (3 of 4)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Kamrup Metro, Assam | Court case (Motor Vehicle Act) | Filed against the company by State of Assam | Pending |
| District court, Kamrup Metro, Assam | Court case (Complaint Case C.R.) | Filed by the company against an individual | Disposed |
| District court, Ahmedabad, Gujarat | Court case (TMSUIT) | Filed against the company by Rits Pharma | Disposed |
To see the full case history of Intag Remedies Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Intag Remedies Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Intag Remedies Private Limited has a workforce of 56 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Employee count
56
Active EPFO establishments
1
Employee growth
3.7%
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 56 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 |
To see the full employee and EPFO history of Intag Remedies Private Limited, buy the company report.
GST
Intag Remedies has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 18AACCI1905P1ZC | Assam | Active | 01 Jul 2017 |
| 10AACCI1905P1ZS | Bihar | Active | 26 Mar 2019 |
To see the full GST registrations and return filing status of Intag Remedies Private Limited, buy the company report.
Recent activity
Intag Remedies Private Limited has 5 board changes on record since 2008: 5 appointments. The latest: Deepak Damani was appointed as Director on 16 Jul 2008.
AGM
Intag Remedies Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Intag Remedies Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Guwahati.
Appointed
Deepak Damani was appointed as Director.
Appointed
Bijay Damani Kumar was appointed as Director.
Appointed
Madhu Sudan Periwal was appointed as Director.
Appointed
Narayan Prasad Gattani was appointed as Director.
Appointed
Sarda Devi Damani was appointed as Director.
Incorporation
19 Mar 2008
Intag Remedies Private Limited was registered on 19 Mar 2008 with Roc Guwahati & aged 18 years 7 months as per MCA records.
Frequently asked questions
Intag Remedies is an active private limited company based in Guwahati, Assam, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 19 March 2008 (18+ years old) and is registered under CIN U51397AS2008PTC008633.
Intag Remedies has 5 current directors:
- Deepak Damani - Director
- Narayan Prasad Gattani - Director
- Sarda Devi Damani - Director
- Madhu Sudan Periwal - Director
- Bijay Damani Kumar - Director
The latest financial statements of Intag Remedies on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Intag Remedies is 18AACCI1905P1ZC, registered in Assam. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 10AACCI1905P1ZS (Bihar).
The CIN (Corporate Identification Number) of Intag Remedies is U51397AS2008PTC008633. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Intag Remedies has 4 court cases on record: 1 filed by the company and 3 filed against it. 2 are pending.
Intag Remedies was incorporated on 19 March 2008, making it 18+ years old. It is registered with the Registrar of Companies, Guwahati.
The peers of Intag Remedies by revenue are Medisearch Laboratories (Bombay) Private Limited, Triox Pharmchem Private Limited, Pharvinex Healthcare Private Limited, Acme Therapeutics (I) Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Deepak Damani was appointed as Director on 16 Jul 2008. Bijay Damani Kumar was appointed as Director on 19 Mar 2008. Madhu Sudan Periwal was appointed as Director on 19 Mar 2008. Intag Remedies has 5 board changes on record in total.
Yes, Intag Remedies is registered as a small enterprise under Udyam registration (number: UDYAM-AS-03-0019457).
The registered office of Intag Remedies is at CO Deepak Pharmaceuticals S.C. Goswami Road Pan Bazar, Guwahati, Assam, India – 781001.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages